E. Guler Et Al. , "Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema," CUTANEOUS AND OCULAR TOXICOLOGY , vol.36, no.2, pp.180-184, 2017
Guler, E. Et Al. 2017. Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema. CUTANEOUS AND OCULAR TOXICOLOGY , vol.36, no.2 , 180-184.
Guler, E., Totan, Y., & Guragac, F. B., (2017). Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema. CUTANEOUS AND OCULAR TOXICOLOGY , vol.36, no.2, 180-184.
Guler, Emre, Yuksel Totan, And Fatma Betul Guragac. "Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema," CUTANEOUS AND OCULAR TOXICOLOGY , vol.36, no.2, 180-184, 2017
Guler, Emre Et Al. "Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema." CUTANEOUS AND OCULAR TOXICOLOGY , vol.36, no.2, pp.180-184, 2017
Guler, E. Totan, Y. And Guragac, F. B. (2017) . "Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema." CUTANEOUS AND OCULAR TOXICOLOGY , vol.36, no.2, pp.180-184.
@article{article, author={Emre Guler Et Al. }, title={Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema}, journal={CUTANEOUS AND OCULAR TOXICOLOGY}, year=2017, pages={180-184} }